Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Yasons Chemex Care's Debt-to-EBITDA or its related term are showing as below:
NSE:YCCL's Debt-to-EBITDA is not ranked *
in the Chemicals industry.
Industry Median: 1.97 * Ranked among companies with meaningful Debt-to-EBITDA only.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Yasons Chemex Care Debt-to-EBITDA Related Terms
Yasons Chemex Care Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Yasons Chemex Care's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yasons Chemex Care Debt-to-EBITDA Chart
Yasons Chemex Care Annual Data
Trend
Mar19
Mar20
Mar21
Mar22
Mar23
Debt-to-EBITDA
0.31
0.27
1.26
0.96
0.74
Yasons Chemex Care Semi-Annual Data
Mar19
Mar20
Mar21
Mar22
Mar23
Debt-to-EBITDA
0.31
0.27
1.26
0.96
0.74
NSE:YCCL vs LIN, SHW, ECL: Debt-to-EBITDA Comparison
For the Specialty Chemicals subindustry, Yasons Chemex Care's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yasons Chemex Care Debt-to-EBITDA vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Yasons Chemex Care's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Yasons Chemex Care's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is one times the quarterly (Mar. 2023) EBITDA data.
Yasons Chemex Care (NSE:YCCL) has a Debt-to-EBITDA of 0.74 as of Mar. 2023. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Yasons Chemex Care.
Is Yasons Chemex Care's Debt-to-EBITDA too high?
Yasons Chemex Care's current Debt-to-EBITDA is 0.74. The Chemicals industry median Debt-to-EBITDA is 1.97. Yasons Chemex Care's value of 0.74 is 62.4% below this industry median. Overall, Yasons Chemex Care has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Yasons Chemex Care's Debt-to-EBITDA compare to LIN and SHW?
Yasons Chemex Care's Debt-to-EBITDA of 0.74 can be compared against companies in the Chemicals industry. The industry median Debt-to-EBITDA is 1.97. Yasons Chemex Care's value of 0.74 is 62.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Chemicals company?
The median Debt-to-EBITDA among Chemicals companies is 1.97, based on 1,264 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Yasons Chemex Care's current Debt-to-EBITDA of 0.74 is 62.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Yasons Chemex Care. For the Chemicals industry, the median Debt-to-EBITDA is 1.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yasons Chemex Care's current Debt-to-EBITDA is 0.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yasons Chemex Care stock overvalued right now?
Yasons Chemex Care (NSE:YCCL) has a current Debt-to-EBITDA of 0.74. The current Debt-to-EBITDA is 0.74 and 62.4% below the Chemicals industry median of 1.97. Yasons Chemex Care's overall GF Score™ is 17/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Yasons Chemex Care (NSE:YCCL), the current Debt-to-EBITDA is 0.74 as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Yasons Chemex Care Ltd is engaged in manufacturing dyes & pigment paste, IMCG, and FMCG products. The IMCG products of the company includes Textile dyes, pigments and paints. The Company also manufactures a wide range of pigment paste from various chemicals. Within FMCG it manufactures or packages products such as hair oil, perfumes & deodorant, handmade soap, sanitizer, etc., under its brand name PLXO.
17GF Score
Get the complete analysis for NSE:YCCL
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:YCCL has been successfully added to your 
